24,160.75
(-129.54)
(-0.53%)
10 Jun , 2026 | 04:14 PM
Open
24,313.8
Prev. Close
24,290.3
Market Cap.
₹19,04,098.84
Div Yield
0.75
PE
37.12
PB
37.12
24,119.6
24,497.95
Performance
One Week (%)
1.18
One Month (%)
0.49
One Year (%)
11.28
YTD (%)
10.35
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 26,455 | 26,770 | 25,800 | 9,513 |
Cipla Ltd | 1,377 | 1,391.4 | 1,371.1 | 9,62,642 |
J B Chemicals & Pharmaceuticals Ltd | 2,201.5 | 2,250.3 | 2,190.1 | 2,77,256 |
Dr Reddys Laboratories Ltd | 1,271.7 | 1,283.7 | 1,266.7 | 11,72,155 |
Lupin Ltd | 2,247.2 | 2,280.5 | 2,242.1 | 7,34,927 |
Torrent Pharmaceuticals Ltd | 4,463.7 | 4,560.1 | 4,452.2 | 3,49,028 |
Ipca Laboratories Ltd | 1,630.2 | 1,658.9 | 1,621 | 1,72,179 |
Sun Pharmaceutical Industries Ltd | 1,786.4 | 1,797.6 | 1,771 | 18,82,009 |
Aurobindo Pharma Ltd | 1,453.6 | 1,468.4 | 1,437.1 | 11,23,785 |
Wockhardt Ltd | 1,833 | 1,911.7 | 1,820 | 14,11,114 |
Ajanta Pharma Ltd | 3,074.9 | 3,089.2 | 2,982 | 1,82,466 |
Gland Pharma Ltd | 2,267.8 | 2,341.5 | 2,250 | 3,20,379 |
Biocon Ltd | 414.6 | 421.55 | 412.8 | 30,01,231 |
Alkem Laboratories Ltd | 5,299.5 | 5,470 | 5,286 | 1,17,951 |
Glenmark Pharmaceuticals Ltd | 2,144.4 | 2,252.5 | 2,137.1 | 11,27,230 |
Zydus Lifesciences Ltd | 1,098.3 | 1,119.8 | 1,095.1 | 5,98,159 |
Divis Laboratories Ltd | 6,638.5 | 6,815 | 6,610 | 4,05,743 |
Mankind Pharma Ltd | 2,376.2 | 2,410.6 | 2,366 | 3,63,531 |
Laurus Labs Ltd | 1,385.7 | 1,427 | 1,380.5 | 13,34,485 |
Piramal Pharma Ltd | 164.07 | 170.36 | 162.15 | 12,99,547 |
Indian benchmark indices ended on a mixed note on June 10, 2026, as geopolitical tensions, rising crude oil prices, rupee weakness, and persistent FII selling kept investors cautious. While FMCG and Private Bank stocks provided support, sectors such as Energy, Metals, Realty, and Media witnessed significant selling pressure ahead of key US inflation data.
10 Jun 2026|06:57 PM
The Indian stock market staged a strong recovery on June 9, 2026, as Nifty climbed 119 points and Sensex gained 394 points. Banking stocks surged following RBI's concessional FCNR(B) and ECB swap facilities, while lower crude oil prices, positive global market sentiment, progress in the India-US trade deal, and aviation sector tailwinds supported broad-based buying across Dalal Street.
9 Jun 2026|05:28 PM
Indian benchmark indices ended sharply lower on June 8, 2026, with Nifty closing at 23,123 and Sensex falling 719 points as geopolitical tensions between Iran and Israel, rising crude oil prices, weak global market sentiment, and US rate hike fears triggered a broad-based selloff across sectors.
8 Jun 2026|05:21 PM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
